Anavex Life Sciences Corp (AVXL)

[falconer66a]

But my truths are irrelevant.

The truth surfaces yet again! [Reference to my post# 357383.]

Thanks. I believe what I stated is and will be the more widely-discovered truth regarding blarcamesine.

The truths of blarcamesine’s activation of the sigma-1 receptor protein are available on the various Anavex webpages, and were displayed in the Needham conference. However, they are generally unknown or discounted by the vast majority of both biotech equity investors and professionals in the medical sciences. The personal perspectives of any of those parties can’t change the actual science of blarcamesine operating at the sigma-1 receptor protein. But they can strongly effect public perceptions of both blarcamesine and Anavex Life Sciences Corp.

Simply, blarcamesine’s abilities to either stop, reverse, or prevent various central nervous system (CNS) diseases, as presented by Anavex Life Sciences Corp, are simply too good to be true. It does things no other drug or therapy can, in the CNS of all places. It has virtually no side effects, so extremely rare in drugs acting in the brain, spinal cord, or neurons. That, alone, brings everything into question.

Sure, blarcamesine does miraculous things in transgenic lab rats, with human genes and their diseases. But mice (or rats) are not men. There will be no awards or prizes for rats healed of otherwise un-treatable CNS diseases.

For equity investors, retail or institutional, the only truth that will count will be FDA (or other) approval for sales and therapeutic use of blarcamesine. Of course, that won’t happen until the on-going Phase 3 clinical trials are completed and their results revealed. Until then, late this year or sometime in 2023, message board posters can loudly protest Dr. Missling’s meek, infrequent, or inadequate public pronouncements on his company’s drug. But both, the message board postings, and Anavex’s media releases are irrelevant. The only truth that counts is FDA sales and use approval. Then, the “truth” will be out. Everything will be different.